Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px
Document › Details

4SC AG. (5/14/13). "Press Release: 4SC Significantly Improves Operating Result in First Quarter of 2013 and Resolves to Focus Its Development Strategy". Planegg-Martinsried.

Organisations Organisation 4SC AG (FSE: VSC)
  Group 4SC (Group)
  Organisation 2 BioNTech AG
  Today BioNTech SE
  Group BioNTech (Group)
Products Product resminostat (4SC-201)
  Product 2 drug discovery services
  Index term 2 Leo Pharma–4SC: drug discovery services, 201302– collab €1m upfront + €95m milestones + royalties r+d + commerc drugs for inflammatory skin diseases
Persons Person Spillner, Enno (Evotec 201607– CFO before 4SC CEO + CFO before BioM Venture Capital GmbH)
  Person 2 Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos)
     


   
Record changed: 2017-04-02

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for 4SC (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px




» top